Express News | *The Special Treat Dongfang has been delisted and 19 directors and supervisors have collectively received penalties.

BreakingsApr 30 19:07

Express News | Orient Group Incorporation: The Shanghai Stock Exchange's decision to issue a supervisory warning to the responsible persons of Orient Group Incorporation.

BreakingsApr 30 15:51

Express News | *Special Treat Dongfang: The company's Stocks will be delisted on April 30.

BreakingsApr 28 19:48

Goldman Sachs: Maintains Buy rating on NEW ORIENTAL-S and raises Target Price to 42 HKD.

Goldman Sachs issued a Research Report stating that it will maintain a Buy rating on NEW ORIENTAL-S (09901), with the Target Price raised to HKD 42 based on the sum-of-the-parts valuation method (SOTP). If the company can achieve the guidance for margin expansion in the May quarter, the firm expects investor confidence to gradually improve, and the valuation multiple of NEW ORIENTAL's core Business will slowly increase from the current 1 times 12-month forward PE. The firm gained confidence from the NEW ORIENTAL February quarterly Earnings Reports conference call, where management emphasized its focus on cost control and enhancing operational efficiency, and projected the operating profit margin of NEW ORIENTAL's core Business for the May quarter and the 26 fiscal year.

Sina Hong Kong stocksApr 25 10:33

On April 15, A-shares investment warning | CCCG Real Estate Corporation: net loss of 5.179 billion yuan for the year 2024.

Luoxin Pharmaceuticals Group Stock reported a net loss of 0.962 billion yuan for 2024; Yunnan Coal & Energy reported a net loss of 0.662 billion yuan for 2024; CCCG Real Estate Corporation reported a net loss of 5.179 billion yuan for 2024; Shanxi Guoxin Energy Corporation reported a net loss of 0.34 billion yuan for 2024; Beijing Tongtech received a notice of investigation from the Securities Regulatory Commission due to suspected false records in periodic reports and other financial data; Bidder Pharmaceuticals has terminated its plan to issue shares to purchase assets and raise supporting funds; *ST Oriental received a prior notice of intention to terminate the listing of its stocks; Hainan Shuangcheng Pharmaceuticals' stock trading may be subject to delisting risk warning after the disclosure of the 2024 annual report.

Gelonghui FinanceApr 14 22:43

Express News | *Special Treat Dongfang: Received a notice of intention to terminate the listing of the company's Stocks.

BreakingsApr 14 19:49